Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

OCUL Ocular Therapeutix Inc

4,90

-0,30 (-5,77%)

08 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Ocular Therapeutix (NASDAQ:OCUL)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Ocular Therapeutix Charts.

Ocular Therapeutix (NASDAQ:OCUL)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Ocular Therapeutix Charts.

News Ocular Therapeutix Inc

Ocular Therapeutix® to Host Investor Day on June 13, 2024
Mittwoch 5 Juni 2024 (3 Tage vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 Juni 2024 (4 Tage vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Dienstag 4 Juni 2024 (4 Tage vor) • Edgar (US Regulatory)

Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dienstag 4 Juni 2024 (4 Tage vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 3 Juni 2024 (5 Tage vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 30 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 29 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 28 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 28 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 23 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 23 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Dienstag 7 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere Ocular Therapeutix Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen